Management Team
Stephen R. Davis
Chief Executive Officer
Serge Stankovic, M.D., M.S.P.H.
President
Austin D. Kim
Executive Vice President,
General Counsel and Secretary
Kathie M. Bishop, Ph.D.
Senior Vice President, Head of Rare Disease and External Innovation
Daryl DeKarske
Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences
Stephanie Fagan
Senior Vice President Corporate Affairs and Chief Communications Officer
Charmaine Lykins
Senior Vice President, Global Product Planning and Chief Marketing Officer
Bob Mischler
Senior Vice President, Strategy and Technology Operations
Amanda Morgan
Senior Vice President, Chief Revenue and Customer Officer
Mark Schneyer
Senior Vice President, Business Development, Chief Business Officer and Interim Chief Financial Officer
Ponni Subbiah, M.D., M.P.H.
Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Brendan Teehan
Senior Vice President, Chief Insights & Analytics Officer
Mary Ellen Turner, M.D., M.P.H.
Senior Vice President, Pharmacovigilance and Corporate Safety Officer